MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

A

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Search

Stevanato Group SpA

Chiusa

SettoreSettore sanitario

21.04 -3.8

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

21.01

Massimo

21.32

Metriche Chiave

By Trading Economics

Entrata

10M

49M

Vendite

23M

303M

P/E

Media del settore

35.083

87.826

EPS

0.162

Rendimento da dividendi

0.26

Margine di Profitto

16.205

Dipendenti

5,521

EBITDA

10M

73M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+23.18% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.26%

2.26%

Utili prossimi

5 mar 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-991M

5.7B

Apertura precedente

24.84

Chiusura precedente

21.04

Notizie sul Sentiment di mercato

By Acuity

50%

50%

162 / 370 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Stevanato Group SpA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

10 gen 2026, 00:16 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences Drops Merger With JenaValve

10 gen 2026, 12:00 UTC

Acquisizioni, Fusioni, Takeovers

Copper Is the Prize in Mining Megadeals -- WSJ

10 gen 2026, 09:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

10 gen 2026, 09:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

10 gen 2026, 09:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

9 gen 2026, 22:18 UTC

Discorsi di Mercato

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 gen 2026, 21:50 UTC

Discorsi di Mercato

Energy & Utilities Roundup: Market Talk

9 gen 2026, 21:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

9 gen 2026, 21:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

9 gen 2026, 21:50 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

9 gen 2026, 21:43 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 gen 2026, 20:39 UTC

Discorsi di Mercato

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 gen 2026, 20:38 UTC

Discorsi di Mercato

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 gen 2026, 20:36 UTC

Acquisizioni, Fusioni, Takeovers

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 gen 2026, 20:30 UTC

Discorsi di Mercato

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 gen 2026, 20:15 UTC

Discorsi di Mercato

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 gen 2026, 20:07 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

9 gen 2026, 20:07 UTC

Discorsi di Mercato

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 gen 2026, 19:58 UTC

Acquisizioni, Fusioni, Takeovers

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 gen 2026, 19:42 UTC

Discorsi di Mercato

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 gen 2026, 19:38 UTC

Acquisizioni, Fusioni, Takeovers

Wolters Kluwer Acquires StandardFusion >WTKWY

9 gen 2026, 19:31 UTC

Utili

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 gen 2026, 19:28 UTC

Utili

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 gen 2026, 18:30 UTC

Discorsi di Mercato

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 gen 2026, 18:23 UTC

Discorsi di Mercato

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 gen 2026, 17:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

9 gen 2026, 17:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

9 gen 2026, 17:19 UTC

Discorsi di Mercato

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9 gen 2026, 17:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

9 gen 2026, 17:07 UTC

Discorsi di Mercato

McDonald's Promotions Appear Successful -- Market Talk

Confronto tra pari

Modifica del prezzo

Stevanato Group SpA Previsione

Obiettivo di Prezzo

By TipRanks

23.18% in crescita

Previsioni per 12 mesi

Media 27 USD  23.18%

Alto 30 USD

Basso 24 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stevanato Group SpA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

21.56 / 22.61Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

162 / 370 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat